Physician profile
Mitchell L Devlin
NPI 1700888468
$2,820.63
in general payments reported to CMS, 2019-2025
23 companies · $1,560 in 2025
The $1,560 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $235 · 2020: $119 · 2021: $31.51 · 2022: $191 · 2023: $14.52 · 2024: $670 · 2025: $1,560.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,244.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,244.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $765.82 | 2024-2025 | Onyx Frontier, Symplicity G3, Cobalt Dr Mri Surescan |
| Abiomed | $461.63 | 2019-2025 | Impella |
| Stryker Corporation | $378.83 | 2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S, Flowtriever |
| Abbott Laboratories | $274.50 | 2019-2025 | Perclose Proglide, Perclose Prostyle |
| Edwards Lifesciences Corporation | $174.95 | 2025 | Sapien 3 Ultra Resilia |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $114.22 | 2020-2025 | Lifevest |
| Shockwave Medical, INC | $103.85 | 2024-2025 | Shockwave Intravascular Lithotripsy (Ivl) System With The Shockwave C2+ Coronary, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Biosense Webster, INC. | $102.13 | 2024-2025 | Carto 3 |
| Amgen INC. | $65.22 | 2019-2025 | Repatha, Repatha |
| Boston Scientific Corporation | $65.11 | 2019-2020 | |
| Pfizer INC. | $41.49 | 2019-2025 | |
| Janssen Pharmaceuticals, INC | $38.57 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $34.80 | 2020-2021 | |
| Terumo Medical Corporation | $29.23 | 2023-2025 | Metacross Otw, Glidewire, Heartrail |
| E.R. Squibb & Sons, L.L.C. | $27.83 | 2020-2025 | Eliquis |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $27.62 | 2025 | Inspire |
| Cardiovascular Systems INC. | $22.29 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $19.04 | 2022 | |
| Preventice Services, LLC | $17.25 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $15.05 | 2019 | |
| Bard Peripheral Vascular, INC. | $14.58 | 2022 | |
| Biotronik INC. | $13.96 | 2024 | Orsiro Mission |
| Convatec INC. | $12.66 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mitchell Devlin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.